MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection

Human Immunology

Volumn 72, Issue 10, 2011, Pages 912-915

  Tulio, Siumara ^a,b   Faucz, Fabio R ^b   Werneck, Renata I ^b   Olandoski, Márcia ^b   Alexandre, Rodrigo B ^b   Boldt, Angélica B W ^a   Pedroso, Maria Lucia ^a   De Messias Reason, Iara J ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Chronic hepatitis c; HCV; Hepatitis c virus; Lectin pathway; MASP2

Indexed keywords

ALPHA INTERFERON; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; PEGINTERFERON ALPHA; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAZIL; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY;

EID: 80052961272     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.06.016     Document Type: Article

References (25)

1. Murphy E.L., Fang J., Tu Y., et al. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: Associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis 2010, 202:576-584.
2. Barth H., Liang T.J., Baumert T.F. Hepatitis C virus entry: Molecular biology and clinical implications. Hepatology 2006, 44:527-535.
3. Dustin L.B., Rice C.M. Flying under the radar: The immunobiology of hepatitis C. Annu Rev Immunol 2007, 25:71-99.
4. Thimme R., Lohmann V., Weber F. A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus. Antivir Res 2006, 69:129-141.
5. Segat L., Fabris A., Padovan L., et al. MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma. J Viral Hepat 2008, 15:387-391.
6. Stover C.M., Thiel S., Thelen M., et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 1999, 162:3481-3490.
7. Thiel S., Steffensen R., Christensen I.J., et al. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun 2007, 8:154-163.
8. Thiel S., Kolev M., Degn S., et al. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J Immunol 2009, 182:2939-2947.
9. Brown K.S., Ryder S.D., Irving W.L., Sim R.B., Hickling T.P. Mannan binding lectin and viral hepatitis. Immunol Lett 2007, 108:34-44.
10. Stover C., Endo Y., Takahashi M., et al. The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3. Genes Immun 2001, 2:119-127.
11. Sørensen R., Thiel S., Jensenius J.C. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005, 27:299-319.
12. Ambrus G., Gál P., Kojima M., Szilágyi K., Balczer J., et al. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: A study on recombinant catalytic fragments. J Immunol 2003, 170:1374-1382.
13. Ivanova M., Ruiqing J., Matsushita M., et al. MBL2 single nucleotide polymorphism diversity among four ethnic groups as revealed by a bead-based liquid array profiling. Hum Immunol 2008, 69:877-884.
14. Alves Pedroso M.L., Boldt A.B., Pereira-Ferrari L., et al. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: Association with the severity of liver fibrosis and response to interferon therapy. Clin Exp Immunol 2008, 152:258-264.
15. Bedossa P., Poynard T. An algorithm for the grading of activity in crhonic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
16. Faucz F.R., Gimenez J., Ramos M.D., et al. Cystic fibrosis in a southern Brazilian population: Characteristics of 90% of the alleles. Clin Genet 2007, 72:218-223.
17. Sunyaev S., Ramensky V., Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 2000, 16:198-200.
18. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 2002, 30:3894-3900.
19. Stengaard-Pedersen K., Thiel S., Gadjeva M., et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 2003, 349:554-560.
20. Boldt B.W.A., Luz R.P., Messias-Reason I.J.T. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 2011.
21. Wang Y., Yan J., Shi Y., et al. Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. BMC Infect Dis 2009, 9:51.
22. Brown K.S., Keogh M.J., Owsianka A.M., et al. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010, 1:664-674.
23. Koutsounaki E., Goulielmos G.N., Koulentaki M., Choulaki C., Kouroumalis E., Galanakis E. Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients. J Clin Immunol 2008, 28:495-500.
24. Segat L., Silva V.L.R., Montenegro M.F., Santos S.B., et al. Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection. Clin Immunol 2007, 124:13-17.
25. Halla M.C., do Carmo R.F., Silva V.L.R., et al. Association of hepatitis C virus infection and liver fibrosis severity with the variants alleles of MBL2 gene in a Brazilian population. Hum Immunol 2010, 71:883-887.